{"slug":"vip-tirzepatide","verification":{"valid":true,"entries":2,"head":"5696a9df9d8ee82052ccbc84df673e9886bbad63780563469ade47787d72a3c2"},"energy":{"passes":2,"tokens_in":13630,"tokens_out":3210,"tokens_total":16840,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"5696a9df9d8ee82052ccbc84df673e9886bbad63780563469ade47787d72a3c2"},"provenance":[{"ts":"2026-06-29T22:14:49.159Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Tirzepatide\nSlug: vip-tirzepatide\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"dual_compound\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"},{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"},{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 c","response":"{\n  \"slug\": \"vip-tirzepatide\",\n  \"title\": \"VIP and Tirzepatide: Layered Evidence on Immune/Autonomic and Metabolic Pathways\",\n  \"body\": \"## What's breaking down\\n\\nDegeneration can occur across multiple layers. One layer involves immune and autonomic signaling, where unchecked inflammation or disrupted nerve-immune communication may slow tissue repair. Another layer involves metabolic load, where excess body weight increases compressive forces on joints and the spine over time. When repair pathways lag behind these breakdown signals, the imbalance can persist. VIP is discussed in the context of the immune/autonomic layer. Tirzepatide is discussed in the context of the metabolic load layer. No single condition is assumed here.\\n\\n## Why VIP might help you\\n\\n1. **What keeps failing:** Immune and autonomic signaling can contribute to ongoing inflammation or poor tissue coordination if that layer is active in your situation.\\n2. **What VIP is studied to do:** VIP targets repair pathways in tissue through immune modulation rather than symptom masking.\\n3. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## Why Tirzepatide might help you\\n\\n1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n2. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n3. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\\n\\n## How these fit together\\n\\nEach compound above targets a different degeneration layer. Together they are a stack — not five copies of the same mechanism.\\n- VIP → immune / autonomic\\n- Tirzepatide → metabolic load / body weight\\n\\n## What the evidence actually shows\\n\\nVIP human data come mainly from small trials in pulmonary hypertension (one","tokens_in":13630,"tokens_out":3210,"cost":0,"prev":"genesis","hash":"6ed9ec5534b76be094a6f8eb408361934ee23f5ab6af78039b1cad5c579ead48"},{"ts":"2026-07-17T02:43:28.148Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-tirzepatide","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6ed9ec5534b76be094a6f8eb408361934ee23f5ab6af78039b1cad5c579ead48","hash":"5696a9df9d8ee82052ccbc84df673e9886bbad63780563469ade47787d72a3c2"}]}